Market Place
Sourcing Support
Amring Appoints Eric D. Donnenfeld, MD as Medical Advisory Board Chair
26 Feb 2024 //
BUSINESSWIRE
Nordic Pharma Completes Acquisition of Visant Medical
18 Dec 2023 //
BUSINESSWIRE
Enforcement Report - Week of June 21, 2023
21 Jun 2023 //
FDA
Amring Pharmaceuticals Inc. Joins End Drug Shortages Alliance
29 Jun 2022 //
BUSINESSWIRE
Amring Pharma Announces Launch of Timolol Maleate Ophthalmic Solution, USP 0.5%
23 Jun 2022 //
BUSINESSWIRE
Amring Pharma Bags Approval of Generic Lamotrigine Orally Disintegrating Tablets
14 Feb 2022 //
BUSINESSWIRE
Amring Pharms` Generic Lamotrigine Receives Approval in the U.S.
03 Feb 2022 //
FDA
Amzell,B.V., in Collaboration With Amring Pharmaceuticals Inc. Announce
19 Nov 2021 //
BUSINESSWIRE
Amzell, Amring`s AMZ002 Enters Phase III Trial for Infantile Epileptic Disease
19 Nov 2021 //
BUSINESSWIRE
Amring Pharmaceuticals Inc. Licenses LYSTEDA to Pierre Fabre for Mexican Market
29 Sep 2021 //
BUSINESSWIRE
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.